查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2065219

人工智慧驅動的臨床決策支援市場預測至2034年：全球分析（按組件、部署模式、技術、資料來源整合、應用、最終用戶和地區分類）

AI-Powered Clinical Decision Support Market Forecasts to 2034 - Global Analysis By Component (Software and Services), Deployment Mode, Technology, Data Source Integration, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球人工智慧驅動的臨床決策支援市場預計將在 2026 年達到 32 億美元，到 2034 年達到 148 億美元，在預測期內以 18.7% 的複合年成長率成長。

人工智慧驅動的臨床決策支援系統（AI-CDSS）是指利用人工智慧、機器學習和自然語言處理等先進軟體系統，幫助醫療專業人員做出實證臨床決策。這些平台整合來自多個資訊來源的患者數據，包括電子健康記錄、醫學影像、檢驗結果和基因組信息，以產生即時診斷提案、治療方案和風險預警。

對提高診斷準確性和減少臨床錯誤的需求日益成長

全球醫療保健系統面臨著許多根深蒂固的挑戰，例如誤診、治療決策延誤以及因資訊過載而導致的醫師職業倦怠。人工智慧臨床決策支援系統（AI-CDSS）平台透過即時處理大量結構化和非結構化臨床數據來應對這些挑戰，使醫生能夠更快、更準確地做出決策。預測分析和自然語言處理的整合使臨床醫生能夠在現場獲得循證建議，從而減少可預防的不利事件。隨著醫院越來越重視病人安全指標和基於價值的醫療保健結果，採用人工智慧驅動的決策工具正成為一項重要的策略營運投資。

監管複雜性和數據互通性障礙

在醫療設備監管法規結構複雜且瞬息萬變的背景下，人工智慧臨床決策支援系統（AI-CDSS）平台的推廣應用面臨著許多挑戰，尤其是在需要符合FDA和CE認證要求的市場。新AI演算法的核准需要嚴格的臨床檢驗、模型可解釋性的透明度以及持續的上市後監測。此外，醫療資訊生態系統的碎片化、電子健康記錄（EHR）標準的差異以及醫院系統間有限的互通性都阻礙了資料的無縫整合。 IT預算有限的小規模醫療機構往往缺乏有效實施AI所需的必要基礎設施，從而阻礙了AI在不同醫療環境中的市場滲透。

擴大以價值為導向的醫療保健和醫院數位化舉措

全球向基於價值的醫療保健補償模式的轉變，催生了對人工智慧臨床決策支援系統（AI-CDSS）工具的強勁需求，這些工具能夠在降低成本的同時顯著改善治療效果。各國政府和保險公司正鼓勵醫院採用數位健康技術，以支持社區健康管理、慢性病監測和預防性醫療保健策略。同時，新興市場的大規模電子健康記錄現代化專案正在產生可用於人工智慧模型的清晰、結構化的資料集。這些協同因素為與尋求可衡量效率的醫療保健系統合作的AI-CDSS供應商帶來了龐大的商機。

演算法偏見和臨床醫生對人工智慧驅動的建議缺乏信任。

人工智慧臨床決策支援系統（AI-CDSS）推廣應用的一大障礙是演算法偏差。這意味著，基於歷史資料偏差訓練的模型可能會對不同族群產生不公平的推薦。臨床醫生也對深度學習模式的不透明性表示擔憂，認為其難以理解或質疑人工智慧生成的推薦。這會削弱人們對該技術的信心，並導致自動化偏差甚至直接拒絕。此外，在大多數司法管轄區，人工智慧驅動的臨床決策所涉及的法律責任問題仍存在法律上的模糊之處，缺乏明確的監管指南，使得醫院管理者不願將這些工具全面整合到標準治療方案中。

新冠疫情的感染疾病：

新冠疫情加速了人工智慧臨床決策支援系統（AI-CDSS，即「綜合殘疾狀況輔助系統」）的應用，因為醫療系統不堪重負，迫切需要分診決策支援、重症監護室資源分配工具和預測風險分層平台。這場危機展現了人工智慧在應對患者數量激增和優先處理關鍵干預措施方面所能帶來的實際價值。疫情過後，醫療系統正加速推動數位藍圖，並投資可互通的人工智慧工具。疫情也凸顯了快速知識整合能力的重要性，使AI-CDSS成為現代醫院營運和長期照護規劃中不可或缺的基礎設施層。

在預測期內，軟體領域預計將佔據最大的市場佔有率。

預計在預測期內，軟體領域將佔據最大的市場佔有率，這主要得益於醫院和醫療網路中知識庫系統和預測分析平台的廣泛應用。軟體解決方案可與電子病歷 (EHR) 基礎設施直接整合，從而實現即時臨床警報和建議的無縫交付。對基於自然語言處理 (NLP) 的臨床引擎和診斷支援模組的持續投入，進一步鞏固了軟體作為全球人工智慧臨床決策支援系統 (AI-CDSS) 生態系統基礎層的主導地位。

預計在預測期內，服務業板塊將呈現最高的複合年成長率。

在預測期內，服務領域預計將呈現最高的成長率。這反映出，隨著醫療系統應對人工智慧部署帶來的複雜挑戰，對諮詢、整合和託管支援服務的需求日益成長。隨著醫療機構越來越意識到持續客製化、員工培訓和系統最佳化對於成功實施人工智慧臨床決策支援系統 (AI-CDSS) 的重要性，專業服務合約正在迅速擴張。提供涵蓋從部署到持續模型維護等各個環節的端到端託管服務的供應商，正在這加速部署階段獲得顯著的市場佔有率。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於其高昂的醫療資訊技術支出、成熟的電子病歷基礎設施以及積極主動的人工智慧醫療設備法規結構。美國在人工智慧醫療技術的應用方面處於領先地位，這得益於聯邦政府為促進臨床決策支援系統整合而提供的獎勵，以及眾多人工智慧醫療技術創新者的聚集。完善的報銷機制和強大的實證醫學文化進一步加速了全部區域各大醫院網路對人工智慧醫療技術的應用。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於中國、印度和韓國醫院的快速數位轉型，以及政府對人工智慧驅動的醫療基礎設施投入的增加。慢性病負擔日益加重、農村地區醫生短缺以及醫療保險覆蓋範圍的擴大，都推動了對高度擴充性的決策支援技術的需求。旨在推動人工智慧在初級和三級醫療機構應用的策略性官民合作關係，正使亞太地區在整個預測期內成為發展最快的AI-CDSS市場。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章：執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球人工智慧驅動的臨床決策支援市場：按組件分類

  • 軟體
    • 基於知識的系統
    • 非知識型系統
    • 預測分析平台
    • 基於自然語言處理的臨床引擎
  • 服務
    • 諮詢服務
    • 整合與部署
    • 培訓和支持
    • 維護服務

第6章：全球人工智慧驅動的臨床決策支援市場：按部署模式分類

  • 基於雲端的
  • 現場
  • 混合實現

第7章：全球人工智慧驅動的臨床決策支援市場：按技術分類

  • 機器學習
  • 深度學習
  • 自然語言處理（NLP）
  • 電腦視覺
  • 人工智慧世代
  • 情境感知計算

第8章：全球人工智慧驅動的臨床決策支援市場：按資料來源整合分類

  • 電子健康紀錄（EHR）
  • 醫學影像診斷系統
  • 實驗室資訊系統
  • 穿戴式和遠端監控設備
  • 基因組和生物標記數據
  • 保險理賠和管理數據

第9章：全球人工智慧驅動的臨床決策支援市場：按應用領域分類

  • 診斷決策支持
  • 治療決策支持
  • 治療方案
  • 藥物管理和處方支持
  • 風險預測與預警系統
  • 最佳化臨床工作流程
  • 病患監測
  • 個人化醫療和精準醫療
  • 其他用途

第10章：全球人工智慧驅動的臨床決策支援市場：按最終用戶分類

  • 醫院
  • 私人執業者和診所
  • 門診手術中心
  • 製藥和生物技術公司
  • 研究和學術機構
  • 診斷中心
  • 付款方和保險方
  • 其他最終用戶

第11章 全球人工智慧驅動的臨床決策支援市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • Oracle Health
  • Epic Systems Corporation
  • Siemens Healthineers AG
  • GE HealthCare
  • Koninklijke Philips NV
  • Wolters Kluwer
  • Merative
  • Aidoc
  • Viz.ai
  • IQVIA
  • Elsevier Health
  • Premier, Inc.
  • athenahealth, Inc.
  • Tempus AI
  • Etiometry
Product Code: SMRC36750

According to Stratistics MRC, the Global AI-Powered Clinical Decision Support Market is accounted for $3.2 billion in 2026 and is expected to reach $14.8 billion by 2034, growing at a CAGR of 18.7% during the forecast period. AI-Powered Clinical Decision Support (AI-CDSS) encompasses advanced software systems that leverage artificial intelligence, machine learning, and natural language processing to assist healthcare professionals in making evidence-based clinical decisions. These platforms synthesize patient data from multiple sources including electronic health records, medical imaging, laboratory results, and genomic information to generate real-time diagnostic suggestions, treatment recommendations, and risk alerts.

Market Dynamics:

Driver:

Escalating demand for diagnostic accuracy and reduced clinical errors

Healthcare systems worldwide face persistent challenges related to misdiagnosis, delayed treatment decisions, and physician burnout resulting from information overload. AI-CDSS platforms address these concerns by processing vast volumes of structured and unstructured clinical data in real time, enabling physicians to make faster, more accurate decisions. The integration of predictive analytics and natural language processing allows clinicians to access evidence-based recommendations at the point of care, reducing preventable adverse events. As hospitals increasingly prioritize patient safety metrics and value-based care outcomes, adoption of AI-driven decision tools is being prioritized as a strategic operational investment.

Restraint:

Regulatory complexity and data interoperability barriers

The deployment of AI-CDSS platforms faces significant headwinds from complex and evolving regulatory frameworks governing software as a medical device, particularly in markets governed by FDA and CE mark mandates. Obtaining clearance for new AI algorithms requires rigorous clinical validation, transparency in model explainability, and ongoing post-market surveillance. Additionally, fragmented health information ecosystems, varying EHR standards, and limited interoperability between hospital systems impede seamless data integration. Smaller healthcare institutions with constrained IT budgets often lack the infrastructure needed for effective AI deployment, restricting market penetration across diverse care settings.

Opportunity:

Expansion of value-based care and hospital digitalization initiatives

The global transition toward value-based healthcare reimbursement models is creating powerful demand for AI-CDSS tools that can demonstrably improve outcomes while reducing costs. Governments and payers are incentivizing hospitals to adopt digital health technologies that support population health management, chronic disease monitoring, and preventive care strategies. Simultaneously, large-scale electronic health record modernization programs in emerging markets are generating clean, structured datasets that can be leveraged by AI models. These converging forces present significant commercial opportunities for AI-CDSS vendors to form partnerships with health systems seeking measurable efficiency gains.

Threat:

Algorithmic bias and lack of clinician trust in AI recommendations

A persistent challenge limiting AI-CDSS adoption is the issue of algorithmic bias, where models trained on historically skewed datasets produce inequitable recommendations across demographic groups. Clinicians also express concerns regarding the opacity of deep learning models, making it difficult to understand or challenge AI-generated recommendations. This undermines confidence in the technology and can lead to automation bias or wholesale rejection. Moreover, liability questions surrounding AI-driven clinical decisions remain legally ambiguous in most jurisdictions, discouraging hospital administrators from fully embedding these tools into standard-of-care protocols without clearer regulatory guidance.

Covid-19 Impact:

The COVID-19 pandemic served as a catalyst for AI-CDSS adoption, as overwhelmed healthcare systems urgently required triage decision support, ICU resource allocation tools, and predictive risk stratification platforms. The crisis demonstrated the tangible value of AI in managing patient surges and prioritizing critical interventions. Post-pandemic, health systems have accelerated digital transformation roadmaps, directing capital investments toward interoperable AI tools. The pandemic also highlighted the need for rapid knowledge synthesis capabilities, establishing AI-CDSS as an essential infrastructure layer within modern hospital operations and long-term care planning.

The Software segment is expected to be the largest during the forecast period

The software segment is expected to account for the largest market share during the forecast period, driven by widespread deployment of knowledge-based systems and predictive analytics platforms across hospitals and health networks. Software solutions integrate directly with EHR infrastructure, enabling seamless delivery of real-time clinical alerts and recommendations. Continued investment in NLP-based clinical engines and diagnostic support modules further reinforces software's dominant positioning as the foundational layer of AI-CDSS ecosystems globally.

The Services segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Services segment is predicted to witness the highest growth rate, reflecting growing demand for consulting, integration, and managed support services as health systems navigate complex AI deployment challenges. As institutions increasingly recognize that successful AI-CDSS implementation requires ongoing customization, staff training, and system optimization, specialized service engagements are expanding rapidly. Vendors offering end-to-end managed services encompassing implementation through continuous model maintenance are capturing premium market share during this accelerating adoption phase.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by high healthcare IT expenditure, a mature EHR infrastructure, and an active regulatory pathway for AI-based medical devices. The United States leads adoption, supported by federal incentives promoting clinical decision support integration and a dense concentration of AI health technology innovators. Established reimbursement frameworks and a strong culture of evidence-based medicine further accelerate deployment across major hospital networks throughout the region.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, propelled by rapid hospital digitalization across China, India, and South Korea alongside growing government investment in AI-enabled healthcare infrastructure. Rising chronic disease burdens, physician shortages in rural areas, and expanding health insurance coverage collectively amplify the need for scalable decision support technologies. Strategic public-private partnerships aimed at deploying AI in primary and tertiary care settings are positioning Asia Pacific as the fastest-evolving AI-CDSS market through the forecast period.

Key players in the market

Some of the key players in AI-Powered Clinical Decision Support Market include Oracle Health, Epic Systems Corporation, Siemens Healthineers AG, GE HealthCare, Koninklijke Philips N.V., Wolters Kluwer, Merative, Aidoc, Viz.ai, IQVIA, Elsevier Health, Premier, Inc., athenahealth, Inc., Tempus AI, and Etiometry.

Key Developments:

In March 2026, Oracle Health announced a strategic expansion of its AI-powered clinical decision support suite, integrating advanced generative AI capabilities within its electronic health record platform to enhance real-time diagnostic recommendations and medication management alerts across its global hospital network.

In January 2026, Aidoc secured a significant enterprise agreement with a leading U.S. academic medical center to deploy its AI-CDSS platform across radiology and emergency medicine departments, enabling automated triage prioritization and real-time clinical workflow orchestration at scale.

Components Covered:

  • Software
  • Services

Deployment Modes Covered:

  • Cloud-Based
  • On-Premise
  • Hybrid Deployment

Technologies Covered:

  • Machine Learning
  • Deep Learning
  • Natural Language Processing (NLP)
  • Computer Vision
  • Generative AI
  • Context-Aware Computing

Data Source Integrations Covered:

  • Electronic Health Records (EHR)
  • Medical Imaging Systems
  • Laboratory Information Systems
  • Wearable & Remote Monitoring Devices
  • Genomic & Biomarker Data
  • Claims & Administrative Data

Applications Covered:

  • Diagnostic Decision Support
  • Therapeutic Decision Support
  • Treatment Planning
  • Medication Management & Prescription Support
  • Risk Prediction & Early Warning Systems
  • Clinical Workflow Optimization
  • Patient Monitoring
  • Personalized & Precision Medicine
  • Other Applications

End Users Covered:

  • Hospitals
  • Physician Practices & Clinics
  • Ambulatory Surgical Centers
  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutes
  • Diagnostic Centers
  • Payers & Insurance Providers
  • Other End Users

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global AI-Powered Clinical Decision Support Market, By Component

  • 5.1 Software
    • 5.1.1 Knowledge-Based Systems
    • 5.1.2 Non-Knowledge-Based Systems
    • 5.1.3 Predictive Analytics Platforms
    • 5.1.4 NLP-Based Clinical Engines
  • 5.2 Services
    • 5.2.1 Consulting Services
    • 5.2.2 Integration & Deployment
    • 5.2.3 Training & Support
    • 5.2.4 Maintenance Services

6 Global AI-Powered Clinical Decision Support Market, By Deployment Mode

  • 6.1 Cloud-Based
  • 6.2 On-Premise
  • 6.3 Hybrid Deployment

7 Global AI-Powered Clinical Decision Support Market, By Technology

  • 7.1 Machine Learning
  • 7.2 Deep Learning
  • 7.3 Natural Language Processing (NLP)
  • 7.4 Computer Vision
  • 7.5 Generative AI
  • 7.6 Context-Aware Computing

8 Global AI-Powered Clinical Decision Support Market, By Data Source Integration

  • 8.1 Electronic Health Records (EHR)
  • 8.2 Medical Imaging Systems
  • 8.3 Laboratory Information Systems
  • 8.4 Wearable & Remote Monitoring Devices
  • 8.5 Genomic & Biomarker Data
  • 8.6 Claims & Administrative Data

9 Global AI-Powered Clinical Decision Support Market, By Application

  • 9.1 Diagnostic Decision Support
  • 9.2 Therapeutic Decision Support
  • 9.3 Treatment Planning
  • 9.4 Medication Management & Prescription Support
  • 9.5 Risk Prediction & Early Warning Systems
  • 9.6 Clinical Workflow Optimization
  • 9.7 Patient Monitoring
  • 9.8 Personalized & Precision Medicine
  • 9.9 Other Applications

10 Global AI-Powered Clinical Decision Support Market, By End User

  • 10.1 Hospitals
  • 10.2 Physician Practices & Clinics
  • 10.3 Ambulatory Surgical Centers
  • 10.4 Pharmaceutical & Biotechnology Companies
  • 10.5 Research & Academic Institutes
  • 10.6 Diagnostic Centers
  • 10.7 Payers & Insurance Providers
  • 10.8 Other End Users

11 Global AI-Powered Clinical Decision Support Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Oracle Health
  • 14.2 Epic Systems Corporation
  • 14.3 Siemens Healthineers AG
  • 14.4 GE HealthCare
  • 14.5 Koninklijke Philips N.V.
  • 14.6 Wolters Kluwer
  • 14.7 Merative
  • 14.8 Aidoc
  • 14.9 Viz.ai
  • 14.10 IQVIA
  • 14.11 Elsevier Health
  • 14.12 Premier, Inc.
  • 14.13 athenahealth, Inc.
  • 14.14 Tempus AI
  • 14.15 Etiometry

List of Tables

  • Table 1 Global AI-Powered Clinical Decision Support Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global AI-Powered Clinical Decision Support Market Outlook, By Component (2023-2034) ($MN)
  • Table 3 Global AI-Powered Clinical Decision Support Market Outlook, By Software (2023-2034) ($MN)
  • Table 4 Global AI-Powered Clinical Decision Support Market Outlook, By Knowledge-Based Systems (2023-2034) ($MN)
  • Table 5 Global AI-Powered Clinical Decision Support Market Outlook, By Non-Knowledge-Based Systems (2023-2034) ($MN)
  • Table 6 Global AI-Powered Clinical Decision Support Market Outlook, By Predictive Analytics Platforms (2023-2034) ($MN)
  • Table 7 Global AI-Powered Clinical Decision Support Market Outlook, By NLP-Based Clinical Engines (2023-2034) ($MN)
  • Table 8 Global AI-Powered Clinical Decision Support Market Outlook, By Services (2023-2034) ($MN)
  • Table 9 Global AI-Powered Clinical Decision Support Market Outlook, By Consulting Services (2023-2034) ($MN)
  • Table 10 Global AI-Powered Clinical Decision Support Market Outlook, By Integration & Deployment (2023-2034) ($MN)
  • Table 11 Global AI-Powered Clinical Decision Support Market Outlook, By Training & Support (2023-2034) ($MN)
  • Table 12 Global AI-Powered Clinical Decision Support Market Outlook, By Maintenance Services (2023-2034) ($MN)
  • Table 13 Global AI-Powered Clinical Decision Support Market Outlook, By Deployment Mode (2023-2034) ($MN)
  • Table 14 Global AI-Powered Clinical Decision Support Market Outlook, By Cloud-Based (2023-2034) ($MN)
  • Table 15 Global AI-Powered Clinical Decision Support Market Outlook, By On-Premise (2023-2034) ($MN)
  • Table 16 Global AI-Powered Clinical Decision Support Market Outlook, By Hybrid Deployment (2023-2034) ($MN)
  • Table 17 Global AI-Powered Clinical Decision Support Market Outlook, By Technology (2023-2034) ($MN)
  • Table 18 Global AI-Powered Clinical Decision Support Market Outlook, By Machine Learning (2023-2034) ($MN)
  • Table 19 Global AI-Powered Clinical Decision Support Market Outlook, By Deep Learning (2023-2034) ($MN)
  • Table 20 Global AI-Powered Clinical Decision Support Market Outlook, By Natural Language Processing (NLP) (2023-2034) ($MN)
  • Table 21 Global AI-Powered Clinical Decision Support Market Outlook, By Computer Vision (2023-2034) ($MN)
  • Table 22 Global AI-Powered Clinical Decision Support Market Outlook, By Generative AI (2023-2034) ($MN)
  • Table 23 Global AI-Powered Clinical Decision Support Market Outlook, By Context-Aware Computing (2023-2034) ($MN)
  • Table 24 Global AI-Powered Clinical Decision Support Market Outlook, By Data Source Integration (2023-2034) ($MN)
  • Table 25 Global AI-Powered Clinical Decision Support Market Outlook, By Electronic Health Records (EHR) (2023-2034) ($MN)
  • Table 26 Global AI-Powered Clinical Decision Support Market Outlook, By Medical Imaging Systems (2023-2034) ($MN)
  • Table 27 Global AI-Powered Clinical Decision Support Market Outlook, By Laboratory Information Systems (2023-2034) ($MN)
  • Table 28 Global AI-Powered Clinical Decision Support Market Outlook, By Wearable & Remote Monitoring Devices (2023-2034) ($MN)
  • Table 29 Global AI-Powered Clinical Decision Support Market Outlook, By Genomic & Biomarker Data (2023-2034) ($MN)
  • Table 30 Global AI-Powered Clinical Decision Support Market Outlook, By Claims & Administrative Data (2023-2034) ($MN)
  • Table 31 Global AI-Powered Clinical Decision Support Market Outlook, By Application (2023-2034) ($MN)
  • Table 32 Global AI-Powered Clinical Decision Support Market Outlook, By Diagnostic Decision Support (2023-2034) ($MN)
  • Table 33 Global AI-Powered Clinical Decision Support Market Outlook, By Therapeutic Decision Support (2023-2034) ($MN)
  • Table 34 Global AI-Powered Clinical Decision Support Market Outlook, By Treatment Planning (2023-2034) ($MN)
  • Table 35 Global AI-Powered Clinical Decision Support Market Outlook, By Medication Management & Prescription Support (2023-2034) ($MN)
  • Table 36 Global AI-Powered Clinical Decision Support Market Outlook, By Risk Prediction & Early Warning Systems (2023-2034) ($MN)
  • Table 37 Global AI-Powered Clinical Decision Support Market Outlook, By Clinical Workflow Optimization (2023-2034) ($MN)
  • Table 38 Global AI-Powered Clinical Decision Support Market Outlook, By Patient Monitoring (2023-2034) ($MN)
  • Table 39 Global AI-Powered Clinical Decision Support Market Outlook, By Personalized & Precision Medicine (2023-2034) ($MN)
  • Table 40 Global AI-Powered Clinical Decision Support Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 41 Global AI-Powered Clinical Decision Support Market Outlook, By End User (2023-2034) ($MN)
  • Table 42 Global AI-Powered Clinical Decision Support Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 43 Global AI-Powered Clinical Decision Support Market Outlook, By Physician Practices & Clinics (2023-2034) ($MN)
  • Table 44 Global AI-Powered Clinical Decision Support Market Outlook, By Ambulatory Surgical Centers (2023-2034) ($MN)
  • Table 45 Global AI-Powered Clinical Decision Support Market Outlook, By Pharmaceutical & Biotechnology Companies (2023-2034) ($MN)
  • Table 46 Global AI-Powered Clinical Decision Support Market Outlook, By Research & Academic Institutes (2023-2034) ($MN)
  • Table 47 Global AI-Powered Clinical Decision Support Market Outlook, By Diagnostic Centers (2023-2034) ($MN)
  • Table 48 Global AI-Powered Clinical Decision Support Market Outlook, By Payers & Insurance Providers (2023-2034) ($MN)
  • Table 49 Global AI-Powered Clinical Decision Support Market Outlook, By Other End Users (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.